| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.3 | 3e-07 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.26 | 7e-06 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.26 | 2e-05 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.25 | 2e-05 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.44 | 3e-05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.23 | 5e-05 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.23 | 7e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |